Skip to main content
logo
Boston Scientific Corporation (BVMF:B1SX34)
Brazil flag Brazil · Delayed Price · Currency is BRL
550.98
+9.85 (1.82%)
At close: Nov 12, 2025

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
MedSurg Revenue
6.63B5.99B
Log In
Log In
Log In
Upgrade
Cardiovascular Revenue
12.72B10.76B
Log In
Log In
Log In
Upgrade
Other Segment Revenue
--
Log In
Log In
Log In
Upgrade
Revenue (Other)
1.00M-1.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
19.35B16.75B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Other Segment Revenue
--
Log In
Log In
Log In
Upgrade
U.S Revenue
12.37B10.21B
Log In
Log In
Log In
Upgrade
Europe, Middle East and Africa Revenue
3.35B3.23B
Log In
Log In
Log In
Upgrade
Asia-Pacific Revenue
2.98B2.69B
Log In
Log In
Log In
Upgrade
Latin America and Canada Revenue
654.00M624.00M
Log In
Log In
Log In
Upgrade
Revenue (Other)
1.00M-1.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
19.35B16.75B
Log In
Log In
Log In
Upgrade

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
MedSurg Income Before Taxes
-
Log In
Log In
Log In
Upgrade
Cardiovascular Income Before Taxes
-
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
MedSurg Organic Revenue Growth
7.50%
Log In
Log In
Log In
Upgrade
Rhythm & Neuro Organic Revenue Growth
-
Log In
Log In
Log In
Upgrade
Cardiovascular Organic Revenue Growth
21.90%
Log In
Log In
Log In
Upgrade
Total Organic Revenue Growth
16.40%
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.